Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
William Benton Jones | SVP Pharmaceutical Development | 2024-05-06 | 20,000 | $1.73 | $34.62kBuy |
Richard A. Md Miller | President and CEO | 2024-05-06 | 577,634 | $1.73 | $999.88kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Peter A. Thompson | 10.19% | 6,943,654 | $22.36M | Insider |
Orbimed Advisors LLC | 10.19% | 6,943,654 | $22.36M | Insider |
Orbimed Advisors LLC | 10.19% | 6,943,654 | $22.36M | Institution |
Samlyn Capital LLC | 9.79% | 6,667,105 | $21.47M | Institution |
Ecor1 Capital LLC | 7.58% | 5,162,154 | $16.62M | Insider |
Terry P. Gould | 4.99% | 3,402,422 | $10.96M | Insider |
Adams Street Partners LLC | 4.99% | 3,402,422 | $10.96M | Insider |
Adams Street Partners LLC | 4.81% | 3,275,616 | $10.55M | Institution |
Point72 Asset Management LP | 4.45% | 3,030,011 | $9.76M | Institution |
Rtw Investments LP | 3.93% | 2,679,479 | $8.63M | Institution |